How Do Clinicians Monitor Immunogenicity in Long-Term Peptide Protocols?
Clinicians monitor immunogenicity in long-term peptide protocols by assessing anti-drug antibody formation and its impact on therapeutic efficacy and safety.
HRTioJuly 21, 2025